High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation
Coenzyme Q10 (CoQ10) is a mitochondrial respiratory cofactor and potent endogenous antioxidant. In CoQ10-deficient patients, early treatment with high-oral doses (5–50 mg/kg/day) can limit the progression of renal disease and the onset of neurological manifestations. Crystalline CoQ10 is lipophilic,...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | JOUR |
Materias: | |
Acceso en línea: | http://hdl.handle.net/20.500.12110/paper_03785173_v556_n_p9_Masotta |
Aporte de: |
id |
todo:paper_03785173_v556_n_p9_Masotta |
---|---|
record_format |
dspace |
spelling |
todo:paper_03785173_v556_n_p9_Masotta2023-10-03T15:33:09Z High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation Masotta, N.E. Martinefski, M.R. Lucangioli, S. Rojas, A.M. Tripodi, V.P. Coenzyme Q10 (PubChem CID: 9962735) Coenzyme Q10 stability Coenzyme Q10 treatment Dynamic rheology Dysphagia Ethylcellulose Ethylcellulose (PubChem CID: 24832091) High-dose coenzyme Q10 Lecithin from soybean (PubChem CID: 57369748) MCT oil (PubChem CID: 93356) Oleogels SMS or sorbitan monostearate or Span 60 (PubChem CID: 14928) ethyl cellulose medium chain triacylglycerol phosphatidylcholine ubidecarenone Article bulk density controlled study drug absorption drug formulation drug megadose drug solubility gel glass transition temperature human hydrogen bond kidney disease melting point oleogel priority journal supplementation viscosity Coenzyme Q10 (CoQ10) is a mitochondrial respiratory cofactor and potent endogenous antioxidant. In CoQ10-deficient patients, early treatment with high-oral doses (5–50 mg/kg/day) can limit the progression of renal disease and the onset of neurological manifestations. Crystalline CoQ10 is lipophilic, water-insoluble, and poorly absorbed in the gut. Here, CoQ10 showed low bulk density, another important disadvantage in solid oral formulations. Thus, we propose the use of oleogels to maintain dissolved a high-dose of CoQ10 in medium-chain triglyceride (MCT) oil, using ethylcellulose (EC) for gelling, and a surfactant (sorbitan monostearate –SMS- or lecithin). “True gels” were only obtained with the surfactant presence. Thermoreversible oleogels with 1 g of dissolved CoQ10 per 5 g-disk were successfully developed with proved stability and solubility for 12 months (25.0 °C). SMS was better than lecithin as a surfactant because it allowed lower syneresis, higher CoQ10 retention for 12 months, and notably higher oxidative-stability of the MCT-oil, best immobilized by its true gel network. Plastic deformation without fracture was determined under compression, emulating the soft deformation behavior inside the mouth. SMS-oleogels allowed loading a maximal solubilized CoQ10 dose with maximal stability, and may be easier to swallow by CoQ10-deficient patients who suffer from secondary dysphagia. © 2018 Elsevier B.V. JOUR info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/2.5/ar http://hdl.handle.net/20.500.12110/paper_03785173_v556_n_p9_Masotta |
institution |
Universidad de Buenos Aires |
institution_str |
I-28 |
repository_str |
R-134 |
collection |
Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) |
topic |
Coenzyme Q10 (PubChem CID: 9962735) Coenzyme Q10 stability Coenzyme Q10 treatment Dynamic rheology Dysphagia Ethylcellulose Ethylcellulose (PubChem CID: 24832091) High-dose coenzyme Q10 Lecithin from soybean (PubChem CID: 57369748) MCT oil (PubChem CID: 93356) Oleogels SMS or sorbitan monostearate or Span 60 (PubChem CID: 14928) ethyl cellulose medium chain triacylglycerol phosphatidylcholine ubidecarenone Article bulk density controlled study drug absorption drug formulation drug megadose drug solubility gel glass transition temperature human hydrogen bond kidney disease melting point oleogel priority journal supplementation viscosity |
spellingShingle |
Coenzyme Q10 (PubChem CID: 9962735) Coenzyme Q10 stability Coenzyme Q10 treatment Dynamic rheology Dysphagia Ethylcellulose Ethylcellulose (PubChem CID: 24832091) High-dose coenzyme Q10 Lecithin from soybean (PubChem CID: 57369748) MCT oil (PubChem CID: 93356) Oleogels SMS or sorbitan monostearate or Span 60 (PubChem CID: 14928) ethyl cellulose medium chain triacylglycerol phosphatidylcholine ubidecarenone Article bulk density controlled study drug absorption drug formulation drug megadose drug solubility gel glass transition temperature human hydrogen bond kidney disease melting point oleogel priority journal supplementation viscosity Masotta, N.E. Martinefski, M.R. Lucangioli, S. Rojas, A.M. Tripodi, V.P. High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation |
topic_facet |
Coenzyme Q10 (PubChem CID: 9962735) Coenzyme Q10 stability Coenzyme Q10 treatment Dynamic rheology Dysphagia Ethylcellulose Ethylcellulose (PubChem CID: 24832091) High-dose coenzyme Q10 Lecithin from soybean (PubChem CID: 57369748) MCT oil (PubChem CID: 93356) Oleogels SMS or sorbitan monostearate or Span 60 (PubChem CID: 14928) ethyl cellulose medium chain triacylglycerol phosphatidylcholine ubidecarenone Article bulk density controlled study drug absorption drug formulation drug megadose drug solubility gel glass transition temperature human hydrogen bond kidney disease melting point oleogel priority journal supplementation viscosity |
description |
Coenzyme Q10 (CoQ10) is a mitochondrial respiratory cofactor and potent endogenous antioxidant. In CoQ10-deficient patients, early treatment with high-oral doses (5–50 mg/kg/day) can limit the progression of renal disease and the onset of neurological manifestations. Crystalline CoQ10 is lipophilic, water-insoluble, and poorly absorbed in the gut. Here, CoQ10 showed low bulk density, another important disadvantage in solid oral formulations. Thus, we propose the use of oleogels to maintain dissolved a high-dose of CoQ10 in medium-chain triglyceride (MCT) oil, using ethylcellulose (EC) for gelling, and a surfactant (sorbitan monostearate –SMS- or lecithin). “True gels” were only obtained with the surfactant presence. Thermoreversible oleogels with 1 g of dissolved CoQ10 per 5 g-disk were successfully developed with proved stability and solubility for 12 months (25.0 °C). SMS was better than lecithin as a surfactant because it allowed lower syneresis, higher CoQ10 retention for 12 months, and notably higher oxidative-stability of the MCT-oil, best immobilized by its true gel network. Plastic deformation without fracture was determined under compression, emulating the soft deformation behavior inside the mouth. SMS-oleogels allowed loading a maximal solubilized CoQ10 dose with maximal stability, and may be easier to swallow by CoQ10-deficient patients who suffer from secondary dysphagia. © 2018 Elsevier B.V. |
format |
JOUR |
author |
Masotta, N.E. Martinefski, M.R. Lucangioli, S. Rojas, A.M. Tripodi, V.P. |
author_facet |
Masotta, N.E. Martinefski, M.R. Lucangioli, S. Rojas, A.M. Tripodi, V.P. |
author_sort |
Masotta, N.E. |
title |
High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation |
title_short |
High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation |
title_full |
High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation |
title_fullStr |
High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation |
title_full_unstemmed |
High-dose coenzyme Q10-loaded oleogels for oral therapeutic supplementation |
title_sort |
high-dose coenzyme q10-loaded oleogels for oral therapeutic supplementation |
url |
http://hdl.handle.net/20.500.12110/paper_03785173_v556_n_p9_Masotta |
work_keys_str_mv |
AT masottane highdosecoenzymeq10loadedoleogelsfororaltherapeuticsupplementation AT martinefskimr highdosecoenzymeq10loadedoleogelsfororaltherapeuticsupplementation AT lucangiolis highdosecoenzymeq10loadedoleogelsfororaltherapeuticsupplementation AT rojasam highdosecoenzymeq10loadedoleogelsfororaltherapeuticsupplementation AT tripodivp highdosecoenzymeq10loadedoleogelsfororaltherapeuticsupplementation |
_version_ |
1807320853283602432 |